Skip to main content
. 2023 Mar 2;31(1):13–27. doi: 10.12793/tcp.2023.31.e1

Table 7. Changes in symptom scores between groups.

Duration Test (% difference) Placebo (% difference) p-value
Digestive Behavior Score* (mean ± SD)
Baseline 0.61 ± 0.99 0.48 ± 0.91 0.7039
Day 30 0.13 ± 0.43 (78.69) 0.52 ± 0.78 (8.33)
Day 60 0.06 ± 0.25 (90.19) 0.48 ± 0.83 (0)
Day 90 0.00 ± 0.00 (100) 0.41 ± 0.63 (14.58)
Mean diff (Baseline – Day 30) 0.48 ± 1.00 −0.03 ± 0.82 0.0854
Mean diff (Baseline – Day 60) 0.55 ± 0.96 0.00 ± 0.60 0.0643
Mean diff (Baseline – Day 90) 0.61 ± 0.99 0.07 ± 0.88 0.0818
p-value 0.00007 0.9673
Sleep Quality Score (mean ± SD)
Baseline 7.77 ± 1.67 7.31 ± 1.00 0.2007
Day 30 5.32 ± 1.28 (31.54) 6.76 ± 0.95 (7.52)
Day 60 5.23 ± 0.72 (32.69) 7.10 ± 0.67 (2.87)
Day 90 5.13 ± 0.72 (33.98) 7.07 ± 0.88 (3.28)
Mean diff (Baseline – Day 30) 2.45 ± 1.75 0.55 ± 0.83 < 0.001
Mean diff (Baseline – Day 60) 2.55 ± 1.61 0.21 ± 1.24 < 0.001
Mean diff (Baseline – Day 90) 2.65 ± 1.85 0.24 ± 1.46 < 0.001
p-value < 0.001 0.1318

*Data analyzed by Wilcoxan signed ranked test within groups and Mann Whitney U test between groups. Significant at p < 0.05.

Data analyzed by Student’s t-test.